CH Biotech R&D Co., Ltd. (TPE:6534)
92.10
-3.00 (-3.15%)
Aug 1, 2025, 1:30 PM CST
Alteryx Market Cap
CH Biotech R&D has a market cap or net worth of 9.47 billion as of July 31, 2025. Its market cap has increased by 9.77% in one year.
Market Cap
9.47B
Enterprise Value
9.57B
Revenue
1.66B
Ranking
n/a
PE Ratio
20.88
Stock Price
$92.10
Market Cap Chart
Since July 2, 2015, CH Biotech R&D's market cap has increased from 7.47B to 9.47B, an increase of 26.75%. That is a compound annual growth rate of 2.38%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 9.78B | 17.70% |
Dec 31, 2024 | 8.31B | 0.37% |
Dec 29, 2023 | 8.28B | 13.05% |
Dec 30, 2022 | 7.32B | 42.15% |
Dec 30, 2021 | 5.15B | 20.79% |
Dec 31, 2020 | 4.26B | -25.79% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
China Steel | 292.79B |
Nan Ya Plastics | 284.32B |
Formosa Plastics | 246.99B |
TCC Group Holdings | 181.50B |
Formosa Chemicals & Fibre | 157.63B |
Asia Cement | 142.22B |
Walsin Lihwa | 92.39B |
Ta Chen Stainless Pipe | 84.90B |